Medolife Rx Presents Its Venom-To-Drug Development Projects at an International Conference Held in the Dominican Republic

January 11, 2022

Lexaria Discusses Valuation Metrics for Biotech Industry

August 11, 2022
Better Choice Company Reports Record Second Quarter 2022 Gross Sales and Provides Corporate Update

August 11, 2022
Lexaria Announces Positive Feedback from Pre-IND Meeting with FDA on DehydraTECH-CBD for Hypertension

August 10, 2022
The Alkaline Water Company Completes Company-Wide Review and Identifies Approximately $15 Million in Cost Savings and Margin Enhancements

August 9, 2022